Cargando…

Validation of early myocardial gadolinium enhancement (EGE) evaluation with "Lake Louise consensus" criteria in patients with suspected myocarditis using a single bolus of 0.1 mmol/Kg of a high relaxivity gadolinium-based contrast agent

Detalles Bibliográficos
Autores principales: Galea, Nicola, Carbone, Iacopo, Fiorelli, Andrea, Noce, Vincenzo, Ciolina, Federica, Francone, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328153/
http://dx.doi.org/10.1186/1532-429X-17-S1-P292
_version_ 1782357193914318848
author Galea, Nicola
Carbone, Iacopo
Fiorelli, Andrea
Noce, Vincenzo
Ciolina, Federica
Francone, Marco
author_facet Galea, Nicola
Carbone, Iacopo
Fiorelli, Andrea
Noce, Vincenzo
Ciolina, Federica
Francone, Marco
author_sort Galea, Nicola
collection PubMed
description
format Online
Article
Text
id pubmed-4328153
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43281532015-02-15 Validation of early myocardial gadolinium enhancement (EGE) evaluation with "Lake Louise consensus" criteria in patients with suspected myocarditis using a single bolus of 0.1 mmol/Kg of a high relaxivity gadolinium-based contrast agent Galea, Nicola Carbone, Iacopo Fiorelli, Andrea Noce, Vincenzo Ciolina, Federica Francone, Marco J Cardiovasc Magn Reson Poster Presentation BioMed Central 2015-02-03 /pmc/articles/PMC4328153/ http://dx.doi.org/10.1186/1532-429X-17-S1-P292 Text en Copyright © 2015 Galea et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Galea, Nicola
Carbone, Iacopo
Fiorelli, Andrea
Noce, Vincenzo
Ciolina, Federica
Francone, Marco
Validation of early myocardial gadolinium enhancement (EGE) evaluation with "Lake Louise consensus" criteria in patients with suspected myocarditis using a single bolus of 0.1 mmol/Kg of a high relaxivity gadolinium-based contrast agent
title Validation of early myocardial gadolinium enhancement (EGE) evaluation with "Lake Louise consensus" criteria in patients with suspected myocarditis using a single bolus of 0.1 mmol/Kg of a high relaxivity gadolinium-based contrast agent
title_full Validation of early myocardial gadolinium enhancement (EGE) evaluation with "Lake Louise consensus" criteria in patients with suspected myocarditis using a single bolus of 0.1 mmol/Kg of a high relaxivity gadolinium-based contrast agent
title_fullStr Validation of early myocardial gadolinium enhancement (EGE) evaluation with "Lake Louise consensus" criteria in patients with suspected myocarditis using a single bolus of 0.1 mmol/Kg of a high relaxivity gadolinium-based contrast agent
title_full_unstemmed Validation of early myocardial gadolinium enhancement (EGE) evaluation with "Lake Louise consensus" criteria in patients with suspected myocarditis using a single bolus of 0.1 mmol/Kg of a high relaxivity gadolinium-based contrast agent
title_short Validation of early myocardial gadolinium enhancement (EGE) evaluation with "Lake Louise consensus" criteria in patients with suspected myocarditis using a single bolus of 0.1 mmol/Kg of a high relaxivity gadolinium-based contrast agent
title_sort validation of early myocardial gadolinium enhancement (ege) evaluation with "lake louise consensus" criteria in patients with suspected myocarditis using a single bolus of 0.1 mmol/kg of a high relaxivity gadolinium-based contrast agent
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328153/
http://dx.doi.org/10.1186/1532-429X-17-S1-P292
work_keys_str_mv AT galeanicola validationofearlymyocardialgadoliniumenhancementegeevaluationwithlakelouiseconsensuscriteriainpatientswithsuspectedmyocarditisusingasinglebolusof01mmolkgofahighrelaxivitygadoliniumbasedcontrastagent
AT carboneiacopo validationofearlymyocardialgadoliniumenhancementegeevaluationwithlakelouiseconsensuscriteriainpatientswithsuspectedmyocarditisusingasinglebolusof01mmolkgofahighrelaxivitygadoliniumbasedcontrastagent
AT fiorelliandrea validationofearlymyocardialgadoliniumenhancementegeevaluationwithlakelouiseconsensuscriteriainpatientswithsuspectedmyocarditisusingasinglebolusof01mmolkgofahighrelaxivitygadoliniumbasedcontrastagent
AT nocevincenzo validationofearlymyocardialgadoliniumenhancementegeevaluationwithlakelouiseconsensuscriteriainpatientswithsuspectedmyocarditisusingasinglebolusof01mmolkgofahighrelaxivitygadoliniumbasedcontrastagent
AT ciolinafederica validationofearlymyocardialgadoliniumenhancementegeevaluationwithlakelouiseconsensuscriteriainpatientswithsuspectedmyocarditisusingasinglebolusof01mmolkgofahighrelaxivitygadoliniumbasedcontrastagent
AT franconemarco validationofearlymyocardialgadoliniumenhancementegeevaluationwithlakelouiseconsensuscriteriainpatientswithsuspectedmyocarditisusingasinglebolusof01mmolkgofahighrelaxivitygadoliniumbasedcontrastagent